The main purpose of the "Securing America's Drug Supply from Communist China Act" is to enhance the safety and security of pharmaceutical products imported from China. The legislation aims to ensure that drugs coming from Chinese companies are thoroughly reviewed to prevent any potential risks associated with entities linked to the Chinese government or military. Key provisions of the law require the Secretary of Health and Human Services to review all new drug applications submitted by Chinese entities after the law is enacted.